Benefits: Tanzania Cervical Cancer Self-Screening Research Project Fund
Tanzanian woman
Goal $ 2,500.00
13.08% towards our goal
DONOR LIST
Anonymous
$ 50.00
Ryan Demmer
$ 25.00
Very important work!
Heidi Mastrud
$ 7.00
Inspiring research!
Anonymous
$ 25.00
Anonymous
$ 50.00
Dianne Neumark-Sztainer
$ 100.00
Thank you for this important work!
Stacey And David Moe
$ 50.00
Sharanya Johnson
$ 20.00
[Stop]
$ 327.00 raised
Give Now Create your own page

What if women in Tanzania could screen themselves for cervical cancer? You can help us discover the answer on Give to the Max Day!

Despite the fact that vaccines exist to prevent cervical cancer and screening tests exist to detect it, Tanzania has one of the highest rates of cervical cancer in the world. Imagine giving access to women to self-screen for cervical cancer, even in settings in which there are no or limited health care facilities. Our research team will use your donation to study whether self-collected HPV tests can be used to screen women for cervical cancer. Our goal is to demonstrate that this test is excellent at determining who does and does not require follow up and treatment for cervical cancer. We will enroll HIV+ and HIV negative women into our study as being positive increases the risk of cervical cancer more than 20-fold.

Your gift will help:

  • enroll more Tanzanian women in the study and offer screening to them
  • enable our team to better understand whether self-collected HPV tests perform equally well in both HIV positive and HIV negative groups
  • purchase more test kits & process results in a lab
  • sponsor a student researcher on this study so that they have an opportunity to learn about screening for cancer in resource-limited settings

Consider donating today!

  • $7 pays one participant for their time
  • $20 pays for one test kit and lab processing
  • $150 allows us to pay for 10 hours of a student researcher’s time

Imagine how your small gift can make a positive impact on the future health of Tanzanian women. Give today!

This research project is led by Dr. Shalini Kulasingam. Dr. Kulasingam is an associate professor in the Division of Epidemiology and Community Health at the University of Minnesota School of Public Health and a member of the Masonic Cancer Center. Her research interests include human papillomavirus (HPV), cervical cancer, cancer screening, vaccines, and decision and cost-effectiveness modeling. Learn more about Dr. Kulasingam.

Help spread the word

Please help us and let your friends, colleagues and followers know about our page: